Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

MAIA Insider Trading

MAIA Biotechnology, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at MAIA Biotechnology, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-01-12 16:44 2022-09-19 Smith Stan Director BUY $3.69 2,700 $9,959 1,424,178 +0.2%
2025-12-23 16:18 2025-12-22 Smith Stan Director BUY $1.22 57,189 $69,999 1,421,478 +4.2%
2025-12-23 16:16 2025-12-22 CHAOUKI STEVEN M Director BUY $1.22 40,849 $49,999 151,873 +36.8%
2025-12-23 16:14 2025-12-22 Louie Ngar Yee Director BUY $1.22 81,699 $100,000 1,248,888 +7.0%
2025-12-10 00:51 2025-12-05 Smith Stan Director BUY $1.20 13,740 $16,441 4,580 +100.0%
2025-12-04 15:30 2025-11-26 Vitoc Vlad Director, Officer, 10% owner - Chief Executive Officer BUY $1.11 72,000 $79,848 903,421 +8.7%
2025-12-01 14:20 2025-11-26 Vitoc Vlad Director, Officer, 10% owner - Chief Executive Officer BUY $1.11 72,000 $79,848 853,421 +9.2%
2025-12-01 14:18 2025-11-26 Luput Cristian Director BUY $1.10 38,145 $41,845 437,628 +9.5%
2025-12-01 14:14 2025-11-26 Smith Stan Director BUY $1.04 15,000 $15,582 1,364,289 +1.1%
2025-11-28 14:52 2025-11-25 Luput Cristian Director BUY $0.98 10,000 $9,785 399,483 +2.6%
2025-11-28 14:48 2025-11-25 Vitoc Vlad Director, Officer, 10% owner - Chief Executive Officer BUY $0.97 10,500 $10,144 831,421 +1.3%
2025-11-27 00:43 2025-11-24 Smith Stan Director BUY $0.98 25,000 $24,600 1,349,289 +1.9%
2025-11-26 00:15 2025-11-21 Vitoc Vlad Director, Officer, 10% owner - Chief Executive Officer BUY $0.98 11,800 $11,547 820,921 +1.5%
2025-10-02 23:51 2025-10-01 Smith Stan Director BUY $1.30 19,230 $24,999 1,324,289 +1.5%
2025-06-05 23:42 2025-06-03 Smith Stan Director BUY $1.50 33,333 $50,000 1,305,059 +2.6%
2025-05-12 23:14 2025-05-08 Guerrero Ramiro Director BUY $1.50 20,000 $30,000 588,218 +3.5%
2025-05-12 23:12 2025-05-08 Smith Stan Director BUY $1.50 66,666 $99,999 1,271,726 +5.5%
2025-03-06 00:42 2025-03-03 Guerrero Ramiro Director BUY $1.50 33,333 $50,000 568,218 +6.2%
2025-03-06 00:40 2025-03-03 Smith Stan Director BUY $1.50 25,000 $37,500 1,205,060 +2.1%
2025-03-06 00:37 2025-02-24 Guerrero Ramiro Director BUY $1.50 73,333 $110,000 534,885 +15.9%
2025-02-26 00:11 2025-02-24 Guerrero Ramiro Director BUY $1.50 73,333 $110,000 534,885 +15.9%
2025-02-26 00:10 2025-02-24 Smith Stan Director BUY $1.50 50,000 $75,000 1,180,060 +4.4%
2024-12-14 01:17 2024-12-13 Smith Stan Director BUY $1.87 25,000 $46,800 1,130,060 +2.3%
2024-12-14 01:15 2024-12-13 Guerrero Ramiro Director BUY $1.87 53,418 $99,998 514,970 +11.6%
2024-11-05 00:39 2024-11-01 Luput Cristian Director BUY $2.51 22,133 $55,554 389,483 +6.0%
2024-11-05 00:38 2024-11-01 CHAOUKI STEVEN M Director BUY $2.51 22,133 $55,554 111,024 +24.9%
2024-11-05 00:36 2024-11-01 Guerrero Ramiro Director BUY $2.51 88,534 $222,220 408,134 +27.7%
2024-11-05 00:34 2024-11-01 Smith Stan Director BUY $2.51 100,000 $251,000 957,568 +11.7%
2024-04-27 00:33 2024-04-25 Louie Ngar Yee Director BUY $2.03 19,665 $39,920 1,167,189 +1.7%
2024-04-27 00:30 2024-04-25 Smith Stan Director BUY $2.03 147,492 $299,409 1,005,060 +17.2%
2024-03-19 00:34 2024-03-14 CHAOUKI STEVEN M Director BUY $1.17 34,641 $40,530 88,891 +63.9%
2024-03-16 02:11 2024-03-14 Smith Stan Director BUY $1.17 170,940 $200,000 857,568 +24.9%
2024-03-16 02:09 2024-03-14 Louie Ngar Yee Director BUY $1.17 170,940 $200,000 1,147,524 +17.5%
2024-03-16 02:08 2024-03-14 Luput Cristian Director BUY $1.17 69,282 $81,060 367,350 +23.2%
2024-03-16 02:04 2024-03-14 Guerrero Ramiro Director BUY $1.17 6,928 $8,106 319,600 +2.2%
2023-05-22 13:49 2023-05-18 Guerrero Ramiro Director BUY $2.47 1,200 $2,964 312,672 +0.4%
2023-05-17 13:55 2023-05-15 Luput Cristian Director BUY $2.63 3,000 $7,890 298,068 +1.0%
2023-05-01 13:30 2023-04-28 Vitoc Vlad Director, Officer, 10% owner - Chief Executive Officer BUY $2.50 4,000 $10,000 809,121 +0.5%
2023-04-28 13:52 2023-04-27 MCGUIRE JOSEPH F Officer - Chief Financial Officer BUY $2.25 4,400 $9,900 9,400 +88.0%
2023-04-28 13:50 2023-04-27 Guerrero Ramiro Director BUY $2.25 8,500 $19,125 311,472 +2.8%
2023-04-28 13:49 2023-04-27 Louie Ngar Yee Director BUY $2.25 48,000 $108,000 976,584 +5.2%
2023-04-28 13:46 2023-04-27 Smith Stan Director BUY $2.25 133,300 $299,925 686,628 +24.1%
2023-04-21 14:53 2023-04-20 Smith Stan Director BUY $3.74 10,000 $37,400 553,328 +1.8%
2023-04-19 13:55 2023-04-18 Guerrero Ramiro Director BUY $4.17 1,263 $5,267 302,972 +0.4%
2023-04-18 15:42 2023-04-17 Luput Cristian Director BUY $3.69 1,576 $5,815 295,068 +0.5%
2023-04-17 14:01 2023-04-13 Luput Cristian Director BUY $3.60 1,424 $5,123 293,492 +0.5%
2023-04-05 13:48 2023-04-03 Vitoc Vlad Director, Officer, 10% owner - Chief Executive Officer BUY $3.52 2,300 $8,105 805,121 +0.3%
2023-04-03 16:32 2023-03-30 Vitoc Vlad Director, Officer, 10% owner - Chief Executive Officer BUY $3.46 1,700 $5,876 802,821 +0.2%
2023-03-28 14:45 2023-03-24 Smith Stan Director BUY $3.49 938 $3,274 543,328 +0.2%
2023-03-24 15:53 2023-03-22 Smith Stan Director BUY $3.32 3,320 $11,023 542,390 +0.6%
SHOW ENTRIES
1-50 OF 97

How to Interpret $MAIA Trades

Not every insider transaction in MAIA Biotechnology, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MAIA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for MAIA

Insider activity data for MAIA Biotechnology, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MAIA, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.